Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1991-5-7
|
pubmed:abstractText |
Intracellular Ca2+ mobilization events were assessed in mouse L cells, which contain native prostaglandin E1 receptors and transfected human beta 2 adrenergic receptors. Both Fura2 (single cell measurements) and Quin 2, (cuvette assays) were used to determine [Ca2+]i levels. Our results demonstrate that in the transfected cells there is a dose-dependent increase in [Ca2+]i in response to isoproterenol (0.1 nM-100 nM), which is inhibited by the beta-adrenergic antagonist, propranolol, and is a result of intracellular Ca2+ release. [Ca2+]i in these cells was also increased by prostaglandin E1, 8 bromo cyclic AMP, and aluminum fluoride. Both 8 bromo cAMP and isoproterenol induced a rapid increase in the levels of IP1, IP2, and IP3. The data presented demonstrate that the elevation of intracellular cyclic AMP induces an increase in IP3 production which leads to an elevation in [Ca2+]i. We propose that this cyclic AMP dependent activation of the IP3 generating system occurs at a post-receptor site.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0300-8177
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
27
|
pubmed:volume |
101
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
43-9
|
pubmed:dateRevised |
2003-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1849229-Animals,
pubmed-meshheading:1849229-Calcium,
pubmed-meshheading:1849229-Cyclic AMP,
pubmed-meshheading:1849229-Inositol Phosphates,
pubmed-meshheading:1849229-L Cells (Cell Line),
pubmed-meshheading:1849229-Mice,
pubmed-meshheading:1849229-Second Messenger Systems,
pubmed-meshheading:1849229-Transfection
|
pubmed:year |
1991
|
pubmed:articleTitle |
Activation of the inositol trisphosphate second messenger system by cAMP in a mouse fibroblast cell line.
|
pubmed:affiliation |
Clinical Investigations and Patient Care Branch, NIDR, National Institutes of Health, Bethesda, MD 20892.
|
pubmed:publicationType |
Journal Article
|